The Price Tag of Multi-Generational Menopause
For decades, a black box warning sat on menopausal hormone therapy, keeping an entire category of care stigmatized and under-prescribed. The label has been lifted from the prescription; but the stigma at work hasn't. 72% of women have hidden symptoms at work; a third have never told anyone. It still goes unnamed in performance reviews, unaddressed in benefits packages, and undiscussed between colleagues.
That silence hides scale. Perimenopause can begin in a woman's late 30s and persist into her 60s. Roughly a quarter of the U.S. workforce is in it right now, at every level of the org chart.
It also hides cost. Care is fragmented across endocrinology, gynecology, mental health, and primary care, so members cycle through specialists before anyone identifies what's happening. That pre-diagnosis journey can cost more than a full year of comprehensive menopause care — but scattered across claims categories, it never gets totaled, so it never reaches a benefits review.
Join us as we repeal the black box on menopause as a benefit and examine what's actually inside.
You'll leave knowing:
- How many generations of your workforce are affected at once
- Why pre-diagnosis care costs more than your claims data shows
- What a full-lifecycle menopause strategy looks like
- How to build the ROI case for a managed model
